Search Results
Page 98 of 879. Total results: 8787
- https://ansari.house.gov/imo/media/doc/iran_res.pdf...G:\M\19\ANSARI\ANSARI_053.XML g:\VHLC\011226\011226.080.xml (1039625|3) 011226.080.doc 119th CONGRESS 2d Session H. RES. __ Recognizing and expressing support for the Iranian people protesting for a free and democratic Iran. IN THE HOUSE OF REPRESENTATIVES Ms. ...
- https://sykes.house.gov/imo/media/doc/1292026dwclettertodojonepsteinfilescompliance.pdf...Several survivors of Jeffrey Epstein ask Justice Department inspector general to review document redactions and oversight. CNN. https://www.cnn.com/2026/01/14/politics/jeffrey- epstein-survivors-doj-inspector-general 2 Gregorian, D. (2026, January 19). One month after the Epstein files deadline, only a fraction of the DOJ’s records have been released. ...
- https://cuellar.house.gov/uploadedfiles/2026-2027_usmsa_application.docApplication Packet Service Academy Nominations Class of 2031 Congressman Henry Cuellar Attn: Melissa Peña Academy Nominations Coordinator 602 E. Calton Rd., Ste. 2 Laredo, TX 78041 Phone: (956) 725-0639 Fax: (956) 725-2647 Email: Melissa.Pena@mail.house.gov Website: http://house.......
- https://sykes.house.gov/imo/media/doc/james_twoodsletter.pdf...Woods Letter March 18, 2026 Senate Majority Leader John Thune 511 Dirksen Senate Office Building Washington, DC 20510 Democratic Leader Chuck Schumer 322 Hart Senate Office Building Washington, D.C. 20510 Speaker Mike Johnson H-232, The Capitol Washington, D.C. 20515 Democratic Leader Hakeem Jeffries H-204, The Capitol Washington, D.C. 20515 Dear Majority Leader Thune, Democratic Leader Schumer, Speaker Johnson, and Democratic Leader Jeffries, Across the country, millions of children have profiles on the same social media platforms as any adult anywhere in the world. ...
- https://sykes.house.gov/imo/media/doc/harrison_roundabout.pdfFulton/25th/Harrison Roundabout ...
- https://frost.house.gov/imo/media/doc/nice_act.pdfNICE Act No Illegal Captivity and Extensions (NICE) Act To end U.S. Customs and Immigration Enforcement’s (ICE) practice of holding detained immigrants indefinitely without charges. The Issue: U.S. Immigration and Customs Enforcement (ICE) is working with Florida jails to abuse t......
- https://sykes.house.gov/imo/media/doc/dwc_letter.pdf...DWC Smithsonian Letter April 16, 2026 The Honorable Mike Johnson Speaker, U.S. House of Representatives H-232, The Capitol Washington D.C. 20515 Dear Speaker Johnson: As members of the Democratic Women’s Caucus and House Democratic Caucus, we write to express our deep disappointment that House Republicans have derailed a years-long, bipartisan effort to advance the Smithsonian American Women’s History Museum and National Museum of the American Latino. ...
- https://sykes.house.gov/imo/media/doc/project_depot.pdfProject DEPOT ...
- https://sykes.house.gov/imo/media/doc/wise_act.pdf...G:\M\19\WILLGA\WILLGA_121.XML g:\V\H\040326\H040326.030.xml (1053426|1) H040326.030.doc .................................................... (Original Signature of Member) 119th CONGRESS 2d Session H. ...
- https://auchincloss.house.gov/imo/media/doc/20250512legislativesummarynextgenerationusclinicalresearch.pdf...Agency Actions to Create and Expand Point-of-Care Infrastructure • Aligns regulatory requirements for real-world clinical research data with emerging CMS/ONC data and interoperability standards • Accelerates initiatives to validate biomarkers and clinical outcomes assessments relevant to reducing cost and time of point-of-care platforms, and align with use of such measures in federal health care quality improvement initiatives • Requires an interagency implementation plan and an FDA guidance revision addressing cross-agency data modernization and the use of digital/AI tools in point-of-care trials 4. Implementation and Scaling of Point-of-Care Platforms • Directs ARPA-H/NIH implementation of at least 3 lead point-of-care platform opportunities, including applications in rare diseases, high-burden chronic diseases, and other significant unmet needs • Establishes criteria emphasizing feasibility for implementation by non-academic center health care providers and providers serving high-risk patient populations, and participation by a critical mass of biopharma product developers • Authorizes appropriations for CCI activities and platform awards to support the lead pilots and federal technical support for enabling regulatory reforms [including NIH, ARPA-H, and potential user fee sources] • Demonstrates support for a CCI Collaborative for rapid learning and evaluation to increase the initiative’s impact Modernized Preclinical and Early-Stage Clinical Development 5. ...